Safety of an ammonia heart scan at CHUM
Part of Heart & circulation clinical trials.
This trial checks how safe a specific heart scan is when used to look at blood flow to the heart. It is done as part of routine (clinically needed) testing at CHUM, using a special radioactive ammonia tracer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult and be scheduled for a medically needed heart blood-flow scan (PET MPI) at CHUM
- You must be able to undergo the scan in the scanner (not unable due to strong fear or claustrophobia)
- If you are pregnant, you cannot take part
- If you are breastfeeding, you must be willing to temporarily stop during the study
- You must not have a reason you cannot receive the stress-test medicines or the chosen stress method (dipyridamole, aminophylline, dobutamine, or exercise)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a new dye (99mTc-4BOH) with an existing one to see which better shows blockages in heart arteries. If you have chest pain and a confirmed blockage, this trial may help improve detection of coronary artery disease.
This study compares two types of radioactive tracers used during heart PET scans to see if one is better at detecting blocked arteries. Participation involves receiving one of the tracers during your routine scan and may help improve heart disease diagnosis.
This trial uses heart MRI scanning to create normal reference measurements in women who appear to have no heart blood-flow problems. It may help doctors compare future MRI results and better interpret scans when symptoms happen.
This Phase 1 study tests whether a specialized heart MRI injection can show how the heart uses energy. It may help researchers better understand heart muscle thickening and related conditions, and identify heart-related changes early.
This trial tests a very low dose of a radioactive tracer (18F-flurpiridaz) for PET scans of the heart. It aims to see if using less radiation still produces clear images, which may be safer for patients who need repeated scans.
This trial studies a heart scan medicine (99mTc-ECDG) to help evaluate coronary artery disease, a condition caused by narrowed heart arteries. It compares how well the scan works and looks at safety while you undergo standard heart stress imaging.
Hear when a new N-13 Ammonia Safety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.